Overview

PT-141, also known as Bremelanotide, is a synthetic melanocortin receptor agonist studied for its interaction with melanocortin signaling pathways. In laboratory settings, it is examined for receptor-mediated signaling and neurobiological research applications. PT-141 is commonly used in preclinical and experimental research focused on melanocortin receptor activity, peptide signaling, and cellular biology studies. Supplied in lyophilized form for use in controlled laboratory environments. Not for human consumption.